Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1422

1.

TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.

't Hoen E.

Chic J Int Law. 2002 Spring;3(1):27-46. No abstract available.

PMID:
15709298
2.

TRIPS, pharmaceuticals, developing countries, and the Doha "solution".

Sykes AO.

Chic J Int Law. 2002 Spring;3(1):47-68. No abstract available.

PMID:
15709299
3.

Access to essential drugs, human rights and global justice.

Shalev C.

Monash Bioeth Rev. 2004 Jan;23(1):S56-74. No abstract available.

PMID:
15835024
4.

Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?

Oliveira MA, Bermudez JA, Chaves GC, Velásquez G.

Bull World Health Organ. 2004 Nov;82(11):815-21. Epub 2004 Dec 14.

5.

Improving access to medicines in poor countries: the role of universities.

Chokshi DA.

PLoS Med. 2006 Apr;3(6):e136. No abstract available.

6.

Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.

Berger JM.

Conn J Int Law. 2002 Spring;17(2):157-248. No abstract available.

PMID:
12688292
7.

Basic survival needs and access to medicines--coming to grips with TRIPS: conversion + calculation.

Van Puymbroeck RV.

J Law Med Ethics. 2010 Fall;38(3):520-49. doi: 10.1111/j.1748-720X.2010.00510.x.

PMID:
20880239
8.

Balancing access to pharmaceuticals with patent rights.

Nicol D.

Monash Bioeth Rev. 2003 Apr;22(2):50-62.

PMID:
15069957
9.

Developing nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects.

Bird RC.

J Law Med Ethics. 2009 Summer;37(2):209-21. doi: 10.1111/j.1748-720X.2009.00366.x.

PMID:
19493067
10.

Intellectual property rights, the World Trade Organization and public health: the Brazilian perspective.

Viana JM.

Conn J Int Law. 2002 Spring;17(2):311-8. No abstract available.

PMID:
12688298
11.

The GO License: only part of the solution.

Batson A, Milstien JB.

Health Aff (Millwood). 2008 Jan-Feb;27(1):140-2. doi: 10.1377/hlthaff.27.1.140.

12.

Pills, patents, and power: state creation of gray markets as a limit on patent rights.

Ghosh S.

Fla J Int Law. 2002 Spring;14(2):217-60. No abstract available.

PMID:
16526138
13.

Human rights and fair access to medication.

Rubenstein LS.

Emory Int Law Rev. 2003;17:525-34. No abstract available.

PMID:
15732190
14.

Not just a tragedy: access to medications as a right under international law.

Yamin AE.

Boston Univ Int Law J. 2003 Fall;21(2):325-71. No abstract available.

PMID:
16514750
15.

Taking TRIPS to India--Novartis, patent law, and access to medicines.

Mueller JM.

N Engl J Med. 2007 Feb 8;356(6):541-3. No abstract available.

16.

Access to medicines versus access to treatment: the case of type 1 diabetes.

Beran D, McCabe A, Yudkin JS.

Bull World Health Organ. 2008 Aug;86(8):648-9. No abstract available.

17.
18.

The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.

Curti AM.

Am J Law Med. 2001;27(4):469-85. No abstract available.

PMID:
11837145
19.

A fair deal for the future: flexibilities under TRIPS.

So AD.

Bull World Health Organ. 2004 Nov;82(11):813. Epub 2004 Dec 14. No abstract available.

20.

World pharmaceutical developments.

Bale H.

World Hosp Health Serv. 2002;38(2):1. No abstract available.

PMID:
12402745

Supplemental Content

Support Center